HSD11B1L: A Potential Drug Target and Biomarker (G374875)

Target Name: HSD11B1L

NCBI ID: G374875

HSD11B1L: A Potential Drug Target and Biomarker

Human secretory DNAase 11B1 (HSD11B1L) is a gene that encodes a protein involved in the regulation of gene expression and cell signaling pathways. The HSD11B1L gene has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The protein encoded by the HSD11B1L gene is a member of the secretory DNAase family, which includes proteins involved in the delivery of non-coding RNAs (ncRNAs) to the cytoplasm in eukaryotic cells. The HSD11B1L protein has been shown to play a role in the Regulation of gene expression and cell signaling pathways, including the regulation of cell adhesion, migration, and invasion.

In cancer, the HSD11B1L gene has been implicated in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Several studies have shown that high expression of the HSD11B1L gene is associated with poor prognosis in cancer patients. Additionally , the HSD11B1L gene has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to support the growth and expansion of cancer cells. This suggests that the HSD11B1L gene may be involved in the development and progression of cancer by regulating the formation of new blood vessels.

In neurodegenerative diseases, the HSD11B1L gene has been implicated in the development and progression of several types of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Several studies have shown that the HSD11B1L gene is involved in the regulation of neurotransmitter synthesis and release, which is the process by which neurotransmitters are synthesized and released to support the function of nerve cells. Additionally, the HSD11B1L gene has been shown to play a role in the regulation of synaptic plasticity, which is the ability of nerve cells to change and adapt in response to experience.

In autoimmune disorders, the HSD11B1L gene has been implicated in the development and progression of several types of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Several studies have shown that the HSD11B1L gene is involved in the regulation of immune cell function and the production of autoantibodies, which are antibodies that are produced by the immune system to respond to the presence of foreign substances in the body.

Despite the potential implications of the HSD11B1L gene as a drug target and biomarker, further research is needed to fully understand its role in the regulation of gene expression and cell signaling pathways. Several studies have shown that the HSD11B1L gene is involved in the regulation of cell adhesion, migration, and invasion, and that it plays a role in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to determine the full extent of the HSD11B1L gene's involvement in these processes and to develop new treatments based on its potential as a drug target and biomarker.

Protein Name: Hydroxysteroid 11-beta Dehydrogenase 1 Like

More Common Targets